[go: up one dir, main page]

NO20072890L - Behandling av mastitt - Google Patents

Behandling av mastitt

Info

Publication number
NO20072890L
NO20072890L NO20072890A NO20072890A NO20072890L NO 20072890 L NO20072890 L NO 20072890L NO 20072890 A NO20072890 A NO 20072890A NO 20072890 A NO20072890 A NO 20072890A NO 20072890 L NO20072890 L NO 20072890L
Authority
NO
Norway
Prior art keywords
mastitis
treatment
enrofloxacin
ciprofloxacin
cows
Prior art date
Application number
NO20072890A
Other languages
English (en)
Inventor
Franz Pirro
Kristine Fraatz
Robrecht Froyman
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35462240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20072890(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of NO20072890L publication Critical patent/NO20072890L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Det er beskrevet forenklet behandling av mastitt med enrofloxacin eller ciprofloxacin, spesielt i kuer.
NO20072890A 2004-11-12 2007-06-06 Behandling av mastitt NO20072890L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004054873A DE102004054873A1 (de) 2004-11-12 2004-11-12 Behandlung von Mastitis
PCT/EP2005/011553 WO2006050826A2 (de) 2004-11-12 2005-10-28 Behandlung von mastitis mit enrofloxacin

Publications (1)

Publication Number Publication Date
NO20072890L true NO20072890L (no) 2007-06-06

Family

ID=35462240

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072890A NO20072890L (no) 2004-11-12 2007-06-06 Behandling av mastitt

Country Status (27)

Country Link
US (2) US20070265275A1 (no)
EP (1) EP1812002B1 (no)
JP (2) JP2008519781A (no)
KR (1) KR20070084182A (no)
CN (1) CN101056638A (no)
AR (1) AR051763A1 (no)
AT (1) ATE526970T1 (no)
BR (1) BRPI0517473A (no)
CA (1) CA2587187A1 (no)
CR (1) CR9109A (no)
DE (2) DE102004054873A1 (no)
DK (1) DK1812002T3 (no)
ES (1) ES2373449T3 (no)
HR (1) HRP20120002T1 (no)
IL (1) IL182993A (no)
MX (1) MX2007005526A (no)
NO (1) NO20072890L (no)
NZ (1) NZ555062A (no)
PE (1) PE20061139A1 (no)
PL (1) PL1812002T3 (no)
PT (1) PT1812002E (no)
RU (1) RU2413514C2 (no)
SI (1) SI1812002T1 (no)
SV (1) SV2006002296A (no)
UA (1) UA92593C2 (no)
WO (1) WO2006050826A2 (no)
ZA (1) ZA200703695B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5217276B2 (ja) * 2007-07-19 2013-06-19 ニプロ株式会社 注射用抗菌剤の製造方法
GB2480276A (en) * 2010-05-11 2011-11-16 Michael Hilary Burke Process for the preparation of an aqueous injectable enrofloxacin antimicrobial formulation
CN101933927A (zh) * 2010-06-30 2011-01-05 洛阳惠中兽药有限公司 一种含恩诺沙星六水合物组合物及其在制备治疗或预防家畜疾病的药物中的应用
CN104379151A (zh) * 2012-06-29 2015-02-25 拜尔动物保健有限责任公司 药物组合物和乳腺炎的治疗
KR102233537B1 (ko) * 2013-03-15 2021-03-29 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 항균성 폴리아미드 조성물 및 유방염 치료
RU2655772C1 (ru) * 2016-12-26 2018-05-29 Федеральное государственное бюджетное научное учреждение "Курский научно-исследовательский институт агропромышленного производства" Йодсодержащий состав для лечения мастита у коров
RU2652354C1 (ru) * 2017-11-07 2018-04-25 федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный аграрный университет" (ФГБОУ ВО Волгоградский ГАУ) Способ терапии коров, больных маститом
CN108051512A (zh) * 2017-11-27 2018-05-18 佛山科学技术学院 一种牛乳中氟喹诺酮类药物残留量的检测方法
CN110812326B (zh) * 2019-11-04 2022-04-22 黑龙江省农业科学院畜牧兽医分院 一种辛伐他汀混悬乳剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3333719A1 (de) * 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
DE3537761A1 (de) 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
DE19500784A1 (de) 1995-01-13 1996-07-18 Bayer Ag Enrofloxacin-Injektions- oder Infusionslösungen
CA2176298C (en) * 1995-06-27 2009-01-27 Dennis D. Copeland A single high dose fluoroquinolone treatment
GB0229642D0 (en) * 2002-12-20 2003-01-22 Pfizer Ltd Veterinary compositions for treating mastitis

Also Published As

Publication number Publication date
MX2007005526A (es) 2007-07-09
JP2013063985A (ja) 2013-04-11
HRP20120002T1 (hr) 2012-02-29
JP2008519781A (ja) 2008-06-12
IL182993A0 (en) 2007-09-20
ATE526970T1 (de) 2011-10-15
DK1812002T3 (da) 2012-02-06
PT1812002E (pt) 2011-12-30
UA92593C2 (ru) 2010-11-25
IL182993A (en) 2013-03-24
US20070265275A1 (en) 2007-11-15
PE20061139A1 (es) 2006-12-29
DE202005022066U1 (de) 2012-12-06
EP1812002A2 (de) 2007-08-01
WO2006050826A2 (de) 2006-05-18
DE102004054873A1 (de) 2006-05-18
ZA200703695B (en) 2008-08-27
RU2007121516A (ru) 2008-12-20
SV2006002296A (es) 2006-06-26
WO2006050826A3 (de) 2006-07-27
PL1812002T3 (pl) 2012-03-30
SI1812002T1 (sl) 2012-03-30
NZ555062A (en) 2009-12-24
BRPI0517473A (pt) 2008-10-07
RU2413514C2 (ru) 2011-03-10
ES2373449T3 (es) 2012-02-03
US20130023540A1 (en) 2013-01-24
CR9109A (es) 2007-10-04
CA2587187A1 (en) 2006-05-18
EP1812002B1 (de) 2011-10-05
CN101056638A (zh) 2007-10-17
KR20070084182A (ko) 2007-08-24
AR051763A1 (es) 2007-02-07

Similar Documents

Publication Publication Date Title
NO20072890L (no) Behandling av mastitt
IL258702B (en) A pump system for use with organ care systems
MX2009008617A (es) Uso de antagonistas de interleucina-23 para el tratamiento de infeccion.
DK1789419T3 (da) Gyraseinhibitorer og anvendelser deraf
CR20110477A (es) Inhibidores de enzimas de proteina cinasa activadas por mitogeno p38
EA201170227A1 (ru) Имидазолкарбоксамиды
NO20070782L (no) Tetrapeptidanaloger.
UA98629C2 (ru) Соединения и способ модуляции киназ
EA200701918A1 (ru) Белок липокалин
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
UY29183A1 (es) Formulaciones
MX2009012767A (es) Metodos de tratamiento de infecciones fungicas.
NO20082425L (no) Formuleringer omfattende jorumycin-, reni-eramycin-, safracin- eller saframycin-relaterte forbindelser for behandling av proliferative sykdommer
EA200900634A1 (ru) Применение блок-сополимеров на основе виниллактамов и винилацетата в качестве солюбилизаторов
WO2007047608A3 (en) Fibrin targeted therapeutics
EA200801430A1 (ru) Производные триазола
ATE484509T1 (de) Antibakterielle mittel
EA201101300A1 (ru) Способ или система на основе биомаркеров, предназначенная для мониторинга лечения
CY1116166T1 (el) Νεα μεθοδος για την αντιμετωπιση λοιμωξεων απο η.pylori
DE602005015963D1 (de) Estergebundene makrolide, die sich für die behandlung von mikrobiellen infektionen eignen
CY1109803T1 (el) Φαρμακευτικες συνθεσεις που βασιζονται σε ανταγωνιστες νκ2 για παιδιατρικη χρηση
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
MA32355B1 (fr) Association de la dronedarone avec au moins un diuretique, son application en therapeutique
ATE433459T1 (de) Desoxo-nonadepsipeptide
WO2011019423A3 (en) Modulation of pilr receptors to treat microbial infections

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application